Global Stem Cell Therapy Market

- Size, Trend, Share, Opportunity Analysis & Forecast 2014-2025

  • Date Healthcare
  • Date March 2017
  • price $3995
 
 

Global Stem Cell Therapy Market Overview:


Global stem cell therapy market is expected to grow at a CAGR of 12.2% from 2017 to 2025. Stem cell therapy utilizes stem cells for prevention or treatment of various diseases. Research activities have been conducted across the world for development of stem cell therapies for diabetes, heart diseases, and others. It is primarily used in the treatment of cancer along with determining effects on neuronal degeneration, spinal cord injury, multiple sclerosis, and others. Ongoing R&D activities and innovative techniques would foster the growth of the market in the next few years.

Market Drivers and Restraints:

The global stem cell therapy market is driven by factors including rise in funding from various private and government organizations for the R&D activities of stem cell therapy and increase in need for stem cell therapy for the treatment of diseases including cancer. Lack of infrastructure and ethical issues regarding the embryonic stem cells hinder growth in the industry. On the other hand, rise in awareness about the benefits of stem cell therapy and rise in approvals for the clinical trials create new opportunities in the market.

Market Segmentation:

By Therapy Mode

  • Autologous Stem Cell Therapy
    • GIT Diseases
    • CNS Diseases
    • CVS Diseases
    • Wounds and Injuries
    • Musculoskeletal Disorders
    • Others
  • Allogeneic Stem Cell Therapy
    • Wounds and Injuries
    • Musculoskeletal Disorders
    • CNS Diseases
    • Metabolic Diseases
    • Immune System Diseases
    • GIT diseases
    • Eye Diseases
    • CVS Diseases
    • Others

By Application

  • Immune System Diseases
  • GIT Diseases
  • Musculoskeletal Disorders
  • Wounds and Injuries
  • CVS Diseases
  • Eye Diseases
  • Metabolic Diseases
  • CNS Diseases
  • Others

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

Key players operating in the global stem cell therapy market are discussed in the research to help leading players and new entrants determine market competition along with steps to be taken to attain leadership status. Industry players analyzed in the research include Mesoblast Ltd., Aastrom Biosciences Inc., StemCells, Inc., Celgene Corporation, Advanced Cell Technology Inc., Cellaris AB, BioTime Inc., Cellular Engineering Technologies Inc., Living Cell Technologies, and International Stem Cell Corporation. They have adopted various strategies such as mergers & acquisitions, collaborations, expansions, partnerships, joint ventures, and others to consolidate their position in the global industry.

Key Takeaways from the Report:
  • The study provides a comprehensive analysis of the global stem cell therapy market based on changing market dynamics and estimations for the future.  
  • The research offers comprehensive information on changing market trends to assist industry players determine current scenario and investment opportunities.
  • The report offers extensive analysis of drivers, restraints, and opportunities along with their impact on the industry.
  • The research on the global stem cell therapy market provides detailed analysis and statistics for the historic and forecast periods along with strategies to be implemented to gain strong position in the global industry.
  • Trends in the global stem cell therapy market are discussed for the period, 2014–2025, along with financial conditions of the industry.
  • Porter’s Five Forces analysis provides analysis of competitive intensity of the industry and outlines potency of suppliers and buyers.
1. Executive summary
1.1. Key findings
1.2. Market attractiveness and trend analysis
1.3. Competitive landscape and recent industry development analysis
2. Introduction
2.1. Report description
2.2. Scope and definitions
2.3. Research methodology
3. Market landscape
3.1. Growth drivers
3.1.1. Impact analysis
3.2. Restrains and challenges
3.2.1. Impact analysis
3.3. Porters analysis
3.3.1. Bargaining power of buyers
3.3.2. Bargaining power of suppliers
3.3.3. Threat of substitutes
3.3.4. Industry rivalry
3.3.5. Threat of new entrants
3.4. Global stem cell therapy market shares analysis, 2014-2025
3.4.1. Global stem cell therapy market share by product, 2014-2025
3.4.2. Global stem cell therapy market share by type
, 2014-2025
3.4.3. Global stem cell therapy market share by application, 2014-2025
3.4.4. Global stem cell therapy market share by geography, 2014-2025
4. Global stem cell therapy market by therapy mode
4.1. Autologous stem cell therapy
4.1.1. Historical market size by region, 2014-2016
4.1.2. Market forecast by region, 2017-2025
4.1.3. Git diseases
4.1.3.1. Historical market size by region, 2014-2016
4.1.3.2. Market forecast by region, 2017-2025
4.1.4. Cns diseases
4.1.4.1. Historical market size by region, 2014-2016
4.1.4.2. Market forecast by region, 2017-2025
4.1.5. Cvs diseases
4.1.5.1. Historical market size by region, 2014-2016
4.1.5.2. Market forecast by region, 2017-2025
4.1.6. Wounds and injuries
4.1.6.1. Historical market size by region, 2014-2016
4.1.6.2. Market forecast by region, 2017-2025
4.1.7. Musculoskeletal disorders
4.1.7.1. Historical market size by region, 2014-2016
4.1.7.2. Market forecast by region, 2017-2025
4.1.8. Others
4.1.8.1. Historical market size by region, 2014-2016
4.1.8.2. Market forecast by region, 2017-2025
4.2. Allogeneic stem cell therapy
4.2.1. Historical market size by region, 2014-2016
4.2.2. Market forecast by region, 2017-2025
4.2.3. Wounds and injuries
4.2.3.1. Historical market size by region, 2014-2016
4.2.3.2. Market forecast by region, 2017-2025
4.2.4. Musculoskeletal disorders
4.2.4.1. Historical market size by region, 2014-2016
4.2.4.2. Market forecast by region, 2017-2025
4.2.5. Cns diseases
4.2.5.1. Historical market size by region, 2014-2016
4.2.5.2. Market forecast by region, 2017-2025
4.2.6. Metabolic diseases
4.2.6.1. Historical market size by region, 2014-2016
4.2.6.2. Market forecast by region, 2017-2025
4.2.7. Immune system diseases
4.2.7.1. Historical market size by region, 2014-2016
4.2.7.2. Market forecast by region, 2017-2025
4.2.8. Git diseases
4.2.8.1. Historical market size by region, 2014-2016
4.2.8.2. Market forecast by region, 2017-2025
4.2.9. Eye diseases
4.2.9.1. Historical market size by region, 2014-2016
4.2.9.2. Market forecast by region, 2017-2025
4.2.10. Cvs diseases
4.2.10.1. Historical market size by region, 2014-2016
4.2.10.2. Market forecast by region, 2017-2025
4.2.11. Others
4.2.11.1. Historical market size by region, 2014-2016
4.2.11.2. Market forecast by region, 2017-2025
5. Global stem cell therapy market by application
5.1. Immune system diseases
5.1.1. Historical market size by region, 2014-2016
5.1.2. Market forecast by region, 2017-2025
5.2. Git diseases
5.2.1. Historical market size by region, 2014-2016
5.2.2. Market forecast by region, 2017-2025
5.3. Musculoskeletal disorders
5.3.1. Historical market size by region, 2014-2016
5.3.2. Market forecast by region, 2017-2025
5.4. Wounds and injuries
5.4.1. Historical market size by region, 2014-2016
5.4.2. Market forecast by region, 2017-2025
5.5. Cvs diseases
5.5.1. Historical market size by region, 2014-2016
5.5.2. Market forecast by region, 2017-2025
5.6. Eye diseases
5.6.1. Historical market size by region, 2014-2016
5.6.2. Market forecast by region, 2017-2025
5.7. Metabolic diseases
5.7.1. Historical market size by region, 2014-2016
5.7.2. Market forecast by region, 2017-2025
5.8. Cns diseases
5.8.1. Historical market size by region, 2014-2016
5.8.2. Market forecast by region, 2017-2025
5.9. Others
5.9.1. Historical market size by region, 2014-2016
5.9.2. Market forecast by region, 2017-2025
6. Global stem cell therapy market by geography
6.1. North America
6.1.1. U.S.
6.1.1.1. Historical market size, 2014-2016
6.1.1.2. Market forecast, 2017-2025
6.1.2. Canada
6.1.2.1. Historical market size, 2014-2016
6.1.2.2. Market forecast, 2017-2025
6.1.3. Mexico
6.1.3.1. Historical market size, 2014-2016
6.1.3.2. Market forecast, 2017-2025
6.2. Europe
6.2.1. UK
6.2.1.1. Historical market size, 2014-2016
6.2.1.2. Market forecast, 2017-2025
6.2.2. Germany
6.2.2.1. Historical market size, 2014-2016
6.2.2.2. Market forecast, 2017-2025
6.2.3. France
6.2.3.1. Historical market size, 2014-2016
6.2.3.2. Market forecast, 2017-2025
6.2.4. Spain
6.2.4.1. Historical market size, 2014-2016
6.2.4.2. Market forecast, 2017-2025
6.2.5. Italy
6.2.5.1. Historical market size, 2014-2016
6.2.5.2. Market forecast, 2017-2025
6.2.6. Rest of Europe
6.2.6.1. Historical market size, 2014-2016
6.2.6.2. Market forecast, 2017-2025
6.3. Asia-Pacific
6.3.1. China
6.3.1.1. Historical market size, 2014-2016
6.3.1.2. Market forecast, 2017-2025
6.3.2. Japan
6.3.2.1. Historical market size, 2014-2016
6.3.2.2. Market forecast, 2017-2025
6.3.3. India
6.3.3.1. Historical market size, 2014-2016
6.3.3.2. Market forecast, 2017-2025
6.3.4. Australia
6.3.4.1. Historical market size, 2014-2016
6.3.4.2. Market forecast, 2017-2025
6.3.5. South Korea
6.3.5.1. Historical market size, 2014-2016
6.3.5.2. Market forecast, 2017-2025
6.3.6. Rest of Asia-Pacific
6.3.6.1. Historical market size, 2014-2016
6.3.6.2. Market forecast, 2017-2025
6.4. LAMEA
6.4.1. Brazil
6.4.1.1. Historical market size, 2014-2016
6.4.1.2. Market forecast, 2017-2025
6.4.2. South Arabia
6.4.2.1. Historical market size, 2014-2016
6.4.2.2. Market forecast, 2017-2025
6.4.3. South Africa
6.4.3.1. Historical market size, 2014-2016
6.4.3.2. Market forecast, 2017-2025
6.4.4. Rest of LAMEA
6.4.4.1. Historical market size, 2014-2016
6.4.4.2. Market forecast, 2017-2025
7. Company profiles
7.1. Aastrom biosciences inc.
7.1.1. Overview
7.1.2. Financials and business segments
7.1.3. Recent developments
7.2. Mesoblast ltd.
7.2.1. Overview
7.2.2. Financials and business segments
7.2.3. Recent developments
7.3. Celgene corporation
7.3.1. Overview
7.3.2. Financials and business segments
7.3.3. Recent developments
7.4. Stemcells, inc.
7.4.1. overview
7.4.2. Financials and business segments
7.4.3. Recent developments
7.5. Cellaris ab
7.5.1. Overview
7.5.2. Financials and business segments
7.5.3. Recent developments
7.6. Advanced cell technology inc.
7.6.1. Overview
7.6.2. Financials and business segments
7.6.3. Recent developments
7.7. Cellular engineering technologies inc.
7.7.1. Overview
7.7.2. Financials and business segments
7.7.3. Recent developments
7.8. Biotime inc.
7.8.1. overview
7.8.2. Financials and business segments
7.8.3. Recent developments
7.9. Living cell technologies
7.9.1. Overview
7.9.2. Financials and business segments
7.9.3. Recent developments
7.10. International stem cell corporation
7.10.1. Overview
7.10.2. Financials and business segments
7.10.3. Recent developments

List of Tables
Table 1.Stem Cell Therapy Market Share, by Therapy Mode, 2014-2025
Table 2.Stem Cell Therapy Market Share, by Application, 2014-2025
Table 3.Stem Cell Therapy Market Share, by Region, 2017-2025
Table 4.Stem Cell Therapy Market Value for Autologous Stem Cell Therapy, by Type, 2014-2025, $million
Table 5.Stem Cell Therapy Market Value for Autologous Stem Cell Therapy, by Region, 2017-2025, $million
Table 6.Stem Cell Therapy Market Value for GIT Diseases, by Region, 2017-2025, $million
Table 7.Stem Cell Therapy Market Value for CNS Diseases, by Region, 2017-2025, $million
Table 8.Stem Cell Therapy Market Value for CVS Diseases, by Region, 2017-2025, $million
Table 9.Stem Cell Therapy Market Value for Wounds and Injuries, by Region, 2017-2025, $million
Table 10.Stem Cell Therapy Market Value for Musculoskeletal Disorders, by Region, 2017-2025, $million
Table 11.Stem Cell Therapy Market Value for Others, by Region, 2017-2025, $million
Table 12.Stem Cell Therapy Market Value for Allogeneic Stem Cell Therapy, by Type, 2014-2025, $million
Table 13.Stem Cell Therapy Market Value for Allogeneic Stem Cell Therapy, by Region, 2017-2025, $million
Table 14.Stem Cell Therapy Market Value for Wounds and Injuries, by Region, 2017-2025, $million
Table 15.Stem Cell Therapy Market Value for Musculoskeletal Disorders, by Region, 2017-2025, $million
Table 16.Stem Cell Therapy Market Value for CNS Diseases, by Region, 2017-2025, $million
Table 17.Stem Cell Therapy Market Value for Metabolic Diseases, by Region, 2017-2025, $million
Table 18.Stem Cell Therapy Market Value for Immune System Diseases, by Region, 2017-2025, $million
Table 19.Stem Cell Therapy Market Value for GIT diseases, by Region, 2017-2025, $million
Table 20.Stem Cell Therapy Market Value for Eye Diseases, by Region, 2017-2025, $million
Table 21.Stem Cell Therapy Market Value for CVS Diseases, by Region, 2017-2025, $million
Table 22.Stem Cell Therapy Market Value for Others, by Region, 2017-2025, $million
Table 23.Stem Cell Therapy Market Value for Immune System Diseases, by Region, 2017-2025, $million
Table 24.Stem Cell Therapy Market Value for GIT Diseases, by Region, 2017-2025, $million
Table 25.Stem Cell Therapy Market Value for Musculoskeletal Disorders, by Region, 2017-2025, $million
Table 26.Stem Cell Therapy Market Value for Wounds and Injuries, by Region, 2017-2025, $million
Table 27.Stem Cell Therapy Market Value for CVS Diseases, by Region, 2017-2025, $million
Table 28.Stem Cell Therapy Market Value for Eye Diseases, by Region, 2017-2025, $million
Table 29.Stem Cell Therapy Market Value for Metabolic Diseases, by Region, 2017-2025, $million
Table 30.Stem Cell Therapy Market Value for CNS Diseases, by Region, 2017-2025, $million
Table 31.Stem Cell Therapy Market Value for Others, by Region, 2017-2025, $million
Table 32.Stem Cell Therapy Market Value for North America, by Country, 2014-2025, $million
Table 33.Stem Cell Therapy Market Value for North America, by Therapy Mode, 2014-2025, $million
Table 34.Stem Cell Therapy Market Value for North America, by Application, 2014-2025, $million
Table 35.Stem Cell Therapy Market Value for Europe, by Country, 2014-2025, $million
Table 36.Stem Cell Therapy Market Value for Europe, by Therapy Mode, 2014-2025, $million
Table 37.Stem Cell Therapy Market Value for Europe, by Application, 2014-2025, $million
Table 38.Stem Cell Therapy Market Value for Asia-Pacific, by Country, 2014-2025, $million
Table 39.Stem Cell Therapy Market Value for Asia-Pacific, by Therapy Mode, 2014-2025, $million
Table 40.Stem Cell Therapy Market Value for Asia-Pacific, by Application, 2014-2025, $million
Table 41.Stem Cell Therapy Market Value for LAMEA, by Country, 2014-2025, $million
Table 42.Stem Cell Therapy Market Value for LAMEA, by Therapy Mode, 2014-2025, $million
Table 43.Stem Cell Therapy Market Value for LAMEA, by Application, 2014-2025, $million
Table 45. Aastrom Biosciences Inc. - Company Snapshot
Table 46. Mesoblast Ltd. - Company Snapshot
Table 47. Celgene Corporation - Company Snapshot
Table 48. StemCells, Inc. - Company Snapshot
Table 49. Cellaris AB - Company Snapshot
Table 50. Advanced Cell Technology Inc. - Company Snapshot
Table 51. Cellular Engineering Technologies Inc. - Company Snapshot
Table 52. BioTime Inc. - Company Snapshot
Table 53. Living Cell Technologies - Company Snapshot
Table 54. International Stem Cell Corporation - Company Snapshot

List of Figures
Figure 1.Stem Cell Therapy: Autologous Stem Cell Therapy Market Value, 2014-2016, $million
Figure 2.Stem Cell Therapy: GIT Diseases Market Value, 2014-2016, $million
Figure 3.Stem Cell Therapy: CNS Diseases Market Value, 2014-2016, $million
Figure 4.Stem Cell Therapy: CVS Diseases Market Value, 2014-2016, $million
Figure 5.Stem Cell Therapy: Wounds and Injuries Market Value, 2014-2016, $million
Figure 6.Stem Cell Therapy: Musculoskeletal Disorders Market Value, 2014-2016, $million
Figure 7.Stem Cell Therapy: Others Market Value, 2014-2016, $million
Figure 8.Stem Cell Therapy: Allogeneic Stem Cell Therapy Market Value, 2014-2016, $million
Figure 9.Stem Cell Therapy: Wounds and Injuries Market Value, 2014-2016, $million
Figure 10.Stem Cell Therapy: Musculoskeletal Disorders Market Value, 2014-2016, $million
Figure 11.Stem Cell Therapy: CNS Diseases Market Value, 2014-2016, $million
Figure 12.Stem Cell Therapy: Metabolic Diseases Market Value, 2014-2016, $million
Figure 13.Stem Cell Therapy: Immune System Diseases Market Value, 2014-2016, $million
Figure 14.Stem Cell Therapy: GIT diseases Market Value, 2014-2016, $million
Figure 15.Stem Cell Therapy: Eye Diseases Market Value, 2014-2016, $million
Figure 16.Stem Cell Therapy: CVS Diseases Market Value, 2014-2016, $million
Figure 17.Stem Cell Therapy: Others Market Value, 2014-2016, $million
Figure 18.Stem Cell Therapy: Immune System Diseases Market Value, 2014-2016, $million
Figure 19.Stem Cell Therapy: GIT Diseases Market Value, 2014-2016, $million
Figure 20.Stem Cell Therapy: Musculoskeletal Disorders Market Value, 2014-2016, $million
Figure 21.Stem Cell Therapy: Wounds and Injuries Market Value, 2014-2016, $million
Figure 22.Stem Cell Therapy: CVS Diseases Market Value, 2014-2016, $million
Figure 23.Stem Cell Therapy: Eye Diseases Market Value, 2014-2016, $million
Figure 24.Stem Cell Therapy: Metabolic Diseases Market Value, 2014-2016, $million
Figure 25.Stem Cell Therapy: CNS Diseases Market Value, 2014-2016, $million
Figure 26.Stem Cell Therapy: Others Market Value, 2014-2016, $million
Figure 27.Stem Cell Therapy: U.S. Market Value, 2014-2016, $million
Figure 28.Stem Cell Therapy: U.S. Market Value, 2017-2025, $million
Figure 29.Stem Cell Therapy: Canada Market Value, 2014-2016, $million
Figure 30.Stem Cell Therapy: Canada Market Value, 2017-2025, $million
Figure 31.Stem Cell Therapy: Mexico Market Value, 2014-2016, $million
Figure 32.Stem Cell Therapy: Mexico Market Value, 2017-2025, $million
Figure 33.Stem Cell Therapy: UK Market Value, 2014-2016, $million
Figure 34.Stem Cell Therapy: UK Market Value, 2017-2025, $million
Figure 35.Stem Cell Therapy: Germany Market Value, 2014-2016, $million
Figure 36.Stem Cell Therapy: Germany Market Value, 2017-2025, $million
Figure 37.Stem Cell Therapy: France Market Value, 2014-2016, $million
Figure 38.Stem Cell Therapy: France Market Value, 2017-2025, $million
Figure 39.Stem Cell Therapy: Spain Market Value, 2014-2016, $million
Figure 40.Stem Cell Therapy: Spain Market Value, 2017-2025, $million
Figure 41.Stem Cell Therapy: Italy Market Value, 2014-2016, $million
Figure 42.Stem Cell Therapy: Italy Market Value, 2017-2025, $million
Figure 43.Stem Cell Therapy: Rest of Europe Market Value, 2014-2016, $million
Figure 44.Stem Cell Therapy: Rest of Europe Market Value, 2017-2025, $million
Figure 45.Stem Cell Therapy: China Market Value, 2014-2016, $million
Figure 46.Stem Cell Therapy: China Market Value, 2017-2025, $million
Figure 47.Stem Cell Therapy: Japan Market Value, 2014-2016, $million
Figure 48.Stem Cell Therapy: Japan Market Value, 2017-2025, $million
Figure 49.Stem Cell Therapy: India Market Value, 2014-2016, $million
Figure 50.Stem Cell Therapy: India Market Value, 2017-2025, $million
Figure 51.Stem Cell Therapy: Australia Market Value, 2014-2016, $million
Figure 52.Stem Cell Therapy: Australia Market Value, 2017-2025, $million
Figure 53.Stem Cell Therapy: South Korea Market Value, 2014-2016, $million
Figure 54.Stem Cell Therapy: South Korea Market Value, 2017-2025, $million
Figure 55.Stem Cell Therapy: Rest of Asia-Pacific Market Value, 2014-2016, $million
Figure 56.Stem Cell Therapy: Rest of Asia-Pacific Market Value, 2017-2025, $million
Figure 57.Stem Cell Therapy: Brazil Market Value, 2014-2016, $million
Figure 58.Stem Cell Therapy: Brazil Market Value, 2017-2025, $million
Figure 59.Stem Cell Therapy: Saudi Arabia Market Value, 2014-2016, $million
Figure 60.Stem Cell Therapy: Saudi Arabia Market Value, 2017-2025, $million
Figure 61.Stem Cell Therapy: South Africa Market Value, 2014-2016, $million
Figure 62.Stem Cell Therapy: South Africa Market Value, 2017-2025, $million
Figure 63.Stem Cell Therapy: Rest of LAMEA Market Value, 2014-2016, $million
Figure 64.Stem Cell Therapy: Rest of LAMEA Market Value, 2017-2025, $million
License Type
Single User PDF
Enterprise Online /PDF
Price
User / Sharing
Restricted to one authorized user
Unlimited within company / enterprise
Printing
One Print only
Unlimited within company / enterprise
Delivery Formats
ADDED BENIFITS

20% Free customization (Pre-sale)

16 Analyst hour support (Post Sale)

40 Analyst hour support (Post Sale)

160 hours of mini-consult

Free quarterly industry update

Free report on update (within 180 days)

MULTIPLE PURCHASE

Complimentary report with 2 reports

Complimentary report with 3 reports

Subscription Model

 
 

Similar Market Research Report

blog
Sep
2018
Malaysia ABS Pipes Market

ABS pipe, made from thermoplastic polymer resin, is a non-toxic and abrasion-resistant pipe, which is largely used in water supply and sewage projects. The durability of this pipe is high ... Read More >>

 

Get Email Alert